About Bioline  All Journals  Testimonials  Membership  News  Donations

Iranian Journal of Pediatrics
Tehran University of Medical Sciences Press
ISSN: 1018-4406
EISSN: 2008-2150
Vol. 18, No. 1, 2008, pp. 47-52
Bioline Code: pe08007
Full paper language: English
Document type: Research Article
Document available free of charge

Iranian Journal of Pediatrics, Vol. 18, No. 1, 2008, pp. 47-52

 en Pleuropulmonary Manifestations in Juvenile Systemic Lupus Erythematosus; A Review and Descriptive Study in 64 Cases
Moradinejad, Mohammad Hassan & Chitsaz, Sam


Objective: Juvenile systemic lupus erythematosus (JSLE) is a multisystemic autoimmune disease that can involve multiple organs such as: skin, kidney, musculoskeletal system, brain, and others as well as lung. Pulmonarymanifestations may be an initial and/or life-threatening complicationof SLE in children. The aim of this report is to describe the first pleuropulmonary manifestation of childhood lupus erythematosus.
Material & Methods: We studied retrospectively 64 children with JSLE, diagnosed as JSLE at the Children’sMedical Center Hospital between 1995 and2005. All met the American Collegeof Rheumatology (formerly American Rheumatism Association, ARA)revised criteria for SLE. They were evaluated for evidence of pleuro-pulmonaryinvolvement.
Findings: During the 10-yr study period, 64 patients were diagnosedas childhood-onset JSLE, who had the disease at or before the age of 16 (3-16 years). Fifty five patients (86%) were females and 9 patients (14%) were males (female: male ratio=6/1). Mean age of thisgroup at the onset of the disease was 10 years (range 3-16). Eighteen cases (28%) had pulmonary involvement.Pulmonarycomplications include: infectious pneumonia in 38%, pleuritis in 33%, pulmonary vasculitis in 11%, and acute lupus pneumonitis, chronic interstitial pneumonitis and pulmonary embolism (so-called lupus anticoagulant) each one in 5.5%.
Conclusion: The prevalence of pulmonary involvement in patients with JSLE varies according to the method used, but clinically significant pulmonary involvement in our series occurs in approximately 28%. There is few data regarding the treatmentfor most of the immune mediated pulmonary manifestations of JSLE.

Systemic Lupus Erythematosus, Lupus Pneumonitis, Chronic Intestinal Pneumonitis, Pulmonary Hemorrhage, Pneumothorax

© Copyright 2008 - TUMS PUBLICATIONS
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2019, Site last up-dated on 17-Apr-2019.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil